JMJia Ma

Jia Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jia Ma has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Jiye Zhang

    School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China

    2 shared publications
  • Chang Liu

    State Key Laboratory of Oncogenes and Related Genes Center for Single‐Cell Omics School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication
  • Daoxia Guo

    State Key Laboratory of Oncogenes and Related Genes Center for Single‐Cell Omics School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication
  • Fei Mo

    Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, China

    1 shared publication
  • Haiyun Song

    School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

    1 shared publication
  • Jing Huang

    Department of Neurology Xuhui District Central Hospital Shanghai China

    1 shared publication

Latest Publications

  • Open Access

    L‐Se‐methylselenocysteine sensitizes lung carcinoma to chemotherapy

    by Jia Ma, Jing Huang, Jinli Sun, Yanfeng Zhou, Xiaoyuan Ji, Daoxia Guo, Chang Liu, Jiyu Li, Jiye Zhang, Haiyun Song

    Objectives: Organic Selenium (Se) compounds such as L‐Se‐methylselenocysteine (L‐SeMC/SeMC) have been employed as a class of anti‐oxidant to protect normal tissues and organs from chemotherapy‐induced systemic toxicity. However, their comprehensive effects on cancer cell proliferation and tumour progression remain elusive.Materials and Methods: CCK‐8 assays were conducted to determine the viabilities of cancer cells after exposure to SeMC, chemotherapeutics or combined treatment. Intracellular reactive oxygen species (ROS) levels and lipid peroxidation levels were assessed via fluorescence staining. The efficacy of free drugs or drug‐loaded hydrogel against tumour growth was evaluated in a xenograft mouse model.Results: Among tested cancer cells and normal cells, the A549 lung adenocarcinoma cells showed higher sensitivity to SeMC exposure. In addition, combined treatments with several types of chemotherapeutics induced synergistic lethality. SeMC promoted lipid peroxidation in A549 cells and thereby increased ROS generation. Significantly, the in vivo efficacy of combination therapy was largely potentiated by hydrogel‐mediate drug delivery.Conclusions: Our study reveals the selectivity of SeMC in the inhibition of cancer cell proliferation and develops an efficient strategy for local combination therapy.